Company / CIK 0001551152
AbbVie Inc.
- Ticker
- ABBV
- Size, estimated from filings
- Mega cap ($200B and up)
- Insiders on file
- 21
- Members of Congress who traded it
- 6
- Federal contracts on record
- none matched
- Lobbying filings on record
- 49
- SEC filings
- EDGAR ↗
- Latest trade on record
- September 30, 2026
AbbVie Inc. (ABBV) has 21 insiders on file who disclosed 87 transactions in the last 12 months (0 open-market buys, 15 sales, about $61.5M at reported prices), and 12 congressional trades in its stock are on record. No federal contract award that started in the last 180 days was found for a recipient with exactly this name, and 29 lobbying filings naming it as client report $4.8M in 2026.
AbbVie Inc. in charts
Who is trading this stock
Which people account for the buying and selling over the last 12 months?
BoughtSold
8 people account for the disclosed buying and selling in AbbVie Inc. over the last 12 months; the most active is Siatis Perry C with $13M.
Lobbying spend by quarter
How much has AbbVie Inc. reported spending on federal lobbying?
AbbVie Inc. reported $8.2M in lobbying over the last eight quarters, from filings matched by exact company name.
Insiders
| Name | Role | Rows | Bought | Sold | Last filed |
|---|---|---|---|---|---|
| RAPP EDWARD J | Director | 6 | 0 | 0 | October 2, 2026 |
| Quaggin Susan E | Director | 6 | 0 | 0 | October 2, 2026 |
| AUSTIN ROXANNE S | Director | 1 | 0 | 0 | September 15, 2026 |
| Donoghoe Nicholas | EVP, CHIEF BUS/STRAT OFFICER | 9 | 0 | 2 | August 18, 2026 |
| Hart Brett J | Director | 1 | 0 | 0 | July 28, 2026 |
| FALK THOMAS J | Director | 1 | 0 | 0 | May 12, 2026 |
| WADDELL FREDERICK H | Director | 1 | 0 | 0 | May 12, 2026 |
| Roberts Rebecca B | Director | 1 | 0 | 0 | May 12, 2026 |
| MEYER MELODY B | Director | 1 | 0 | 0 | May 12, 2026 |
| BURNSIDE WILLIAM H.L. | Director | 1 | 0 | 0 | May 12, 2026 |
| Davis Jennifer L. | Director | 1 | 0 | 0 | May 12, 2026 |
| FREYMAN THOMAS C | Director | 1 | 0 | 0 | May 12, 2026 |
| SALEKI-GERHARDT AZITA | EVP, CHIEF OPERATIONS OFFICER | 6 | 0 | 1 | May 8, 2026 |
| Alpern Robert J | Director | 3 | 0 | 0 | April 2, 2026 |
| Crum Demetris D | EVP, CHIEF HR OFFICER | 4 | 0 | 1 | March 6, 2026 |
| Purdue David Ryan | SVP, Controller | 7 | 0 | 2 | March 6, 2026 |
| Michael Robert A. | CHIEF EXECUTIVE OFFICER | 6 | 0 | 1 | March 3, 2026 |
| Reents Scott T | EVP, CHIEF FINANCIAL OFFICER | 6 | 0 | 1 | March 3, 2026 |
| Siatis Perry C | EVP, GC AND SECRETARY | 16 | 0 | 5 | March 3, 2026 |
| Stewart Jeffrey Ryan | EVP, CHIEF COMMERCIAL OFFICER | 6 | 0 | 1 | March 3, 2026 |
| Thakkar Roopal | EVP, R&D and CSO | 6 | 0 | 1 | March 3, 2026 |
Rows are this company's Form 4 rows for each person. "Bought" and "sold" count open-market purchases (code P) and sales only. More in insider buying and insider selling.
Members of Congress who traded ABBV
From periodic transaction reports that name the company's stock. Amounts are the sums of the ranges as filed. Every row is on the ABBV page.
| Member | Seat | Trades | Bought | Sold | Range as filed | Latest |
|---|---|---|---|---|---|---|
| Julia Letlow | Representative (LA, District 5), Republican | 4 | 2 | 2 | $4,004–$60K | December 8, 2025 |
| Lisa C. McClain | Representative (MI, District 9), Republican | 3 | 1 | 2 | $3,003–$45K | October 31, 2025 |
| Julie Johnson | Representative (TX, District 32), Democrat | 2 | 0 | 2 | $2,002–$30K | December 18, 2025 |
| Pete Sessions | Representative (TX, District 17), Republican | 1 | 0 | 1 | $15K–$50K | September 14, 2026 |
| Josh Gottheimer | Representative (NJ, District 5), Democrat | 1 | 0 | 1 | $1,001–$15K | May 5, 2026 |
| Alan Armstrong | Senator (OK), Republican | 1 | 1 | 0 | $15K–$50K | March 27, 2026 |
Insider transactions
| Filer | Security | Side | Trade date | Disclosed | Lag | Shares | Price | Value | Flags | Source | Share |
|---|---|---|---|---|---|---|---|---|---|---|---|
| RAPP EDWARD J | ABBV | Other A | September 30, 2026 | October 2, 2026 | 2d | 129 | $262 | $34K | derivative | Form 4 ↗ | |
| Quaggin Susan E | ABBV | Other A | September 30, 2026 | October 2, 2026 | 2d | 59 | $262 | $15K | derivative | Form 4 ↗ | |
| Donoghoe Nicholas | ABBV | Option / conversion M | August 14, 2026 | August 18, 2026 | 4d | 32,710 | — | — | derivative | Form 4 ↗ | |
| Donoghoe Nicholas | ABBV | Sell S | August 14, 2026 | August 18, 2026 | 4d | 32,710 | $250 | $8.2M | Form 4 ↗ | ||
| Donoghoe Nicholas | ABBV | Option / conversion M | August 14, 2026 | August 18, 2026 | 4d | 32,710 | $79 | $2.6M | Form 4 ↗ | ||
| Quaggin Susan E | ABBV | Other A | June 30, 2026 | July 2, 2026 | 2d | 62 | $252 | $16K | derivative | Form 4 ↗ | |
| RAPP EDWARD J | ABBV | Other A | June 30, 2026 | July 2, 2026 | 2d | 134 | $252 | $34K | derivative | Form 4 ↗ | |
| FREYMAN THOMAS C | ABBV | Other A | May 8, 2026 | May 12, 2026 | 4d | 1,118 | — | — | Form 4 ↗ | ||
| Davis Jennifer L. | ABBV | Other A | May 8, 2026 | May 12, 2026 | 4d | 1,118 | — | — | Form 4 ↗ | ||
| BURNSIDE WILLIAM H.L. | ABBV | Other A | May 8, 2026 | May 12, 2026 | 4d | 1,118 | — | — | Form 4 ↗ | ||
| AUSTIN ROXANNE S | ABBV | Other A | May 8, 2026 | May 12, 2026 | 4d | 1,118 | — | — | Form 4 ↗ | ||
| Hart Brett J | ABBV | Other A | May 8, 2026 | May 12, 2026 | 4d | 1,118 | — | — | Form 4 ↗ | ||
| MEYER MELODY B | ABBV | Other A | May 8, 2026 | May 12, 2026 | 4d | 1,118 | — | — | Form 4 ↗ | ||
| Quaggin Susan E | ABBV | Other A | May 8, 2026 | May 12, 2026 | 4d | 1,118 | — | — | Form 4 ↗ | ||
| RAPP EDWARD J | ABBV | Other A | May 8, 2026 | May 12, 2026 | 4d | 1,118 | — | — | Form 4 ↗ | ||
| Roberts Rebecca B | ABBV | Other A | May 8, 2026 | May 12, 2026 | 4d | 1,118 | — | — | Form 4 ↗ | ||
| WADDELL FREDERICK H | ABBV | Other A | May 8, 2026 | May 12, 2026 | 4d | 1,118 | — | — | Form 4 ↗ | ||
| FALK THOMAS J | ABBV | Other A | May 8, 2026 | May 12, 2026 | 4d | 1,118 | — | — | Form 4 ↗ | ||
| Quaggin Susan E | ABBV | Other A | March 31, 2026 | April 2, 2026 | 2d | 71 | $217 | $15K | derivative | Form 4 ↗ | |
| RAPP EDWARD J | ABBV | Other A | March 31, 2026 | April 2, 2026 | 2d | 155 | $217 | $34K | derivative | Form 4 ↗ | |
| Alpern Robert J | ABBV | Other A | March 31, 2026 | April 2, 2026 | 2d | 35 | $217 | $7,612 | derivative | Form 4 ↗ | |
| Purdue David Ryan | ABBV | Sell S | March 4, 2026 | March 6, 2026 | 2d | 5,230 | $234 | $1.2M | Form 4 ↗ | ||
| Crum Demetris D | ABBV | Sell F | February 27, 2026 | March 6, 2026 | 7d | 1,594 | $232 | $370K | late | Form 4 ↗ | |
| Thakkar Roopal | ABBV | Sell F | February 27, 2026 | March 3, 2026 | 4d | 8,037 | $232 | $1.9M | Form 4 ↗ | ||
| Michael Robert A. | ABBV | Sell F | February 27, 2026 | March 3, 2026 | 4d | 36,523 | $232 | $8.5M | Form 4 ↗ | ||
| Stewart Jeffrey Ryan | ABBV | Sell F | February 27, 2026 | March 3, 2026 | 4d | 23,812 | $232 | $5.5M | Form 4 ↗ | ||
| Siatis Perry C | ABBV | Sell S | March 2, 2026 | March 3, 2026 | 1d | 2,600 | $235 | $612K | 10b5-1 plan | Form 4 ↗ | |
| Siatis Perry C | ABBV | Sell S | March 2, 2026 | March 3, 2026 | 1d | 10,291 | $235 | $2.4M | 10b5-1 plan | Form 4 ↗ | |
| Siatis Perry C | ABBV | Sell S | March 2, 2026 | March 3, 2026 | 1d | 5,777 | $234 | $1.3M | 10b5-1 plan | Form 4 ↗ | |
| Siatis Perry C | ABBV | Sell F | February 27, 2026 | March 3, 2026 | 4d | 14,850 | $232 | $3.4M | 10b5-1 plan | Form 4 ↗ | |
| Reents Scott T | ABBV | Sell F | February 27, 2026 | March 3, 2026 | 4d | 21,638 | $232 | $5.0M | Form 4 ↗ | ||
| SALEKI-GERHARDT AZITA | ABBV | Sell F | February 27, 2026 | March 3, 2026 | 4d | 16,309 | $232 | $3.8M | Form 4 ↗ | ||
| Purdue David Ryan | ABBV | Sell F | February 27, 2026 | March 3, 2026 | 4d | 2,692 | $232 | $625K | Form 4 ↗ | ||
| Donoghoe Nicholas | ABBV | Sell F | February 27, 2026 | March 3, 2026 | 4d | 12,874 | $232 | $3.0M | Form 4 ↗ | ||
| Siatis Perry C | ABBV | Option / conversion M | February 25, 2026 | February 27, 2026 | 2d | 7,292 | $193 | $1.4M | 10b5-1 planderivative | Form 4 ↗ | |
| Siatis Perry C | ABBV | Option / conversion M | February 25, 2026 | February 27, 2026 | 2d | 7,775 | $175 | $1.4M | 10b5-1 planderivative | Form 4 ↗ | |
| Siatis Perry C | ABBV | Option / conversion M | February 25, 2026 | February 27, 2026 | 2d | 7,314 | $150 | $1.1M | 10b5-1 planderivative | Form 4 ↗ | |
| Siatis Perry C | ABBV | Sell S | February 25, 2026 | February 27, 2026 | 2d | 22,381 | $230 | $5.1M | 10b5-1 plan | Form 4 ↗ | |
| Siatis Perry C | ABBV | Option / conversion M | February 25, 2026 | February 27, 2026 | 2d | 7,292 | $193 | $1.4M | 10b5-1 plan | Form 4 ↗ | |
| Siatis Perry C | ABBV | Option / conversion M | February 25, 2026 | February 27, 2026 | 2d | 7,775 | $175 | $1.4M | 10b5-1 plan | Form 4 ↗ | |
| Siatis Perry C | ABBV | Option / conversion M | February 25, 2026 | February 27, 2026 | 2d | 7,314 | $150 | $1.1M | 10b5-1 plan | Form 4 ↗ | |
| Thakkar Roopal | ABBV | Other A | February 18, 2026 | February 20, 2026 | 2d | 21,937 | — | — | derivative | Form 4 ↗ | |
| Thakkar Roopal | ABBV | Other A | February 18, 2026 | February 20, 2026 | 2d | 6,638 | — | — | Form 4 ↗ | ||
| Thakkar Roopal | ABBV | Other A | February 18, 2026 | February 20, 2026 | 2d | 3,346 | — | — | Form 4 ↗ | ||
| Thakkar Roopal | ABBV | Other A | February 18, 2026 | February 20, 2026 | 2d | 2,138 | — | — | Form 4 ↗ | ||
| Thakkar Roopal | ABBV | Other A | February 18, 2026 | February 20, 2026 | 2d | 6,015 | — | — | Form 4 ↗ | ||
| Purdue David Ryan | ABBV | Other A | February 18, 2026 | February 20, 2026 | 2d | 4,875 | — | — | derivative | Form 4 ↗ | |
| Purdue David Ryan | ABBV | Other A | February 18, 2026 | February 20, 2026 | 2d | 1,384 | — | — | Form 4 ↗ | ||
| Purdue David Ryan | ABBV | Other A | February 18, 2026 | February 20, 2026 | 2d | 1,292 | — | — | Form 4 ↗ | ||
| Purdue David Ryan | ABBV | Other A | February 18, 2026 | February 20, 2026 | 2d | 890 | — | — | Form 4 ↗ | ||
| Purdue David Ryan | ABBV | Other A | February 18, 2026 | February 20, 2026 | 2d | 2,505 | — | — | Form 4 ↗ | ||
| Stewart Jeffrey Ryan | ABBV | Other A | February 18, 2026 | February 20, 2026 | 2d | 26,812 | — | — | derivative | Form 4 ↗ | |
| Stewart Jeffrey Ryan | ABBV | Other A | February 18, 2026 | February 20, 2026 | 2d | 8,988 | — | — | Form 4 ↗ | ||
| Stewart Jeffrey Ryan | ABBV | Other A | February 18, 2026 | February 20, 2026 | 2d | 9,432 | — | — | Form 4 ↗ | ||
| Stewart Jeffrey Ryan | ABBV | Other A | February 18, 2026 | February 20, 2026 | 2d | 9,266 | — | — | Form 4 ↗ | ||
| Stewart Jeffrey Ryan | ABBV | Other A | February 18, 2026 | February 20, 2026 | 2d | 26,063 | — | — | Form 4 ↗ | ||
| Siatis Perry C | ABBV | Other A | February 18, 2026 | February 20, 2026 | 2d | 19,500 | — | — | derivative | Form 4 ↗ | |
| Siatis Perry C | ABBV | Other A | February 18, 2026 | February 20, 2026 | 2d | 5,808 | — | — | Form 4 ↗ | ||
| Siatis Perry C | ABBV | Other A | February 18, 2026 | February 20, 2026 | 2d | 5,628 | — | — | Form 4 ↗ | ||
| Siatis Perry C | ABBV | Other A | February 18, 2026 | February 20, 2026 | 2d | 5,792 | — | — | Form 4 ↗ | ||
| Siatis Perry C | ABBV | Other A | February 18, 2026 | February 20, 2026 | 2d | 16,290 | — | — | Form 4 ↗ | ||
| SALEKI-GERHARDT AZITA | ABBV | Other A | February 18, 2026 | February 20, 2026 | 2d | 20,312 | — | — | derivative | Form 4 ↗ | |
| SALEKI-GERHARDT AZITA | ABBV | Other A | February 18, 2026 | February 20, 2026 | 2d | 6,638 | — | — | Form 4 ↗ | ||
| SALEKI-GERHARDT AZITA | ABBV | Other A | February 18, 2026 | February 20, 2026 | 2d | 7,074 | — | — | Form 4 ↗ | ||
| SALEKI-GERHARDT AZITA | ABBV | Other A | February 18, 2026 | February 20, 2026 | 2d | 6,058 | — | — | Form 4 ↗ | ||
| SALEKI-GERHARDT AZITA | ABBV | Other A | February 18, 2026 | February 20, 2026 | 2d | 17,041 | — | — | Form 4 ↗ | ||
| Crum Demetris D | ABBV | Other A | February 18, 2026 | February 20, 2026 | 2d | 13,406 | — | — | derivative | Form 4 ↗ | |
| Crum Demetris D | ABBV | Other A | February 18, 2026 | February 20, 2026 | 2d | 1,244 | — | — | Form 4 ↗ | ||
| Crum Demetris D | ABBV | Other A | February 18, 2026 | February 20, 2026 | 2d | 1,216 | — | — | Form 4 ↗ | ||
| Donoghoe Nicholas | ABBV | Other A | February 18, 2026 | February 20, 2026 | 2d | 20,312 | — | — | derivative | Form 4 ↗ | |
| Donoghoe Nicholas | ABBV | Other A | February 18, 2026 | February 20, 2026 | 2d | 6,222 | — | — | Form 4 ↗ | ||
| Donoghoe Nicholas | ABBV | Other A | February 18, 2026 | February 20, 2026 | 2d | 5,172 | — | — | Form 4 ↗ | ||
| Donoghoe Nicholas | ABBV | Other A | February 18, 2026 | February 20, 2026 | 2d | 4,632 | — | — | Form 4 ↗ | ||
| Donoghoe Nicholas | ABBV | Other A | February 18, 2026 | February 20, 2026 | 2d | 13,031 | — | — | Form 4 ↗ | ||
| Reents Scott T | ABBV | Other A | February 18, 2026 | February 20, 2026 | 2d | 21,937 | — | — | derivative | Form 4 ↗ | |
| Reents Scott T | ABBV | Other A | February 18, 2026 | February 20, 2026 | 2d | 7,260 | — | — | Form 4 ↗ | ||
| Reents Scott T | ABBV | Other A | February 18, 2026 | February 20, 2026 | 2d | 7,606 | — | — | Form 4 ↗ | ||
| Reents Scott T | ABBV | Other A | February 18, 2026 | February 20, 2026 | 2d | 8,910 | — | — | Form 4 ↗ | ||
| Reents Scott T | ABBV | Other A | February 18, 2026 | February 20, 2026 | 2d | 25,062 | — | — | Form 4 ↗ | ||
| Michael Robert A. | ABBV | Other A | February 18, 2026 | February 20, 2026 | 2d | 81,251 | — | — | derivative | Form 4 ↗ | |
| Michael Robert A. | ABBV | Other A | February 18, 2026 | February 20, 2026 | 2d | 22,124 | — | — | Form 4 ↗ | ||
| Michael Robert A. | ABBV | Other A | February 18, 2026 | February 20, 2026 | 2d | 14,452 | — | — | Form 4 ↗ | ||
| Michael Robert A. | ABBV | Other A | February 18, 2026 | February 20, 2026 | 2d | 12,030 | — | — | Form 4 ↗ | ||
| Michael Robert A. | ABBV | Other A | February 18, 2026 | February 20, 2026 | 2d | 33,833 | — | — | Form 4 ↗ | ||
| Alpern Robert J | ABBV | Other A | December 31, 2025 | January 5, 2026 | 5d | 34 | $228 | $7,769 | latederivative | Form 4 ↗ | |
| Quaggin Susan E | ABBV | Other A | December 31, 2025 | January 5, 2026 | 5d | 68 | $228 | $16K | latederivative | Form 4 ↗ | |
| RAPP EDWARD J | ABBV | Other A | December 31, 2025 | January 5, 2026 | 5d | 147 | $228 | $34K | latederivative | Form 4 ↗ | |
| Quaggin Susan E | ABBV | Other A | September 30, 2025 | October 2, 2025 | 2d | 67 | $232 | $16K | derivative | Form 4 ↗ | |
| Alpern Robert J | ABBV | Other A | September 30, 2025 | October 2, 2025 | 2d | 33 | $232 | $7,641 | derivative | Form 4 ↗ | |
| RAPP EDWARD J | ABBV | Other A | September 30, 2025 | October 2, 2025 | 2d | 145 | $232 | $34K | derivative | Form 4 ↗ |
Federal contracts (USAspending, awards started in the last 180 days)
No contract award starting in the last 180 days was found for a recipient named exactly "AbbVie Inc.". Subsidiaries and differently-spelled recipients are not matched — search contracts.
Lobbying (Senate LDA, as client)
| Period | Registrant | Primary issue | Amount | Source |
|---|---|---|---|---|
| 2026 Q3 | CORNERSTONE GOVERNMENT AFFAIRS, INC. | Health Issues | $80,000 | LDA ↗ |
| 2026 Q3 | FEDERAL STREET STRATEGIES, LLC | Health Issues | $50,000 | LDA ↗ |
| 2026 Q3 | TIBER CREEK GROUP | Medicare/Medicaid | $30,000 | LDA ↗ |
| 2026 Q2 | ABBVIE, INC. | Copyright/Patent/Trademark | $1,160,000 | LDA ↗ |
| 2026 Q2 | WILLIAMS AND JENSEN, PLLC | Medicare/Medicaid | $90,000 | LDA ↗ |
| 2026 Q2 | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Health Issues | $90,000 | LDA ↗ |
| 2026 Q2 | CORNERSTONE GOVERNMENT AFFAIRS, INC. | Health Issues | $80,000 | LDA ↗ |
| 2026 Q2 | CAPITOL TAX PARTNERS, LLP | Taxation/Internal Revenue Code | $80,000 | LDA ↗ |
| 2026 Q2 | ACG ADVOCACY | Trade (domestic/foreign) | $60,000 | LDA ↗ |
| 2026 Q2 | TARPLIN, DOWNS & YOUNG, LLC | Medicare/Medicaid | $60,000 | LDA ↗ |
| 2026 Q2 | MARSHALL & POPP, LLC | Pharmacy | $60,000 | LDA ↗ |
| 2026 Q2 | FEDERAL STREET STRATEGIES, LLC | Health Issues | $50,000 | LDA ↗ |
| 2026 Q2 | W STRATEGIES, LLC | Medicare/Medicaid | $50,000 | LDA ↗ |
| 2026 Q2 | CHECKMATE GOVERNMENT RELATIONS | Health Issues | — | LDA ↗ |
| 2026 Q2 | BAKER & HOSTETLER LLP | — | — | LDA ↗ |
| 2026 Q1 | ABBVIE, INC. | Copyright/Patent/Trademark | $2,080,000 | LDA ↗ |
| 2026 Q1 | CHECKMATE GOVERNMENT RELATIONS | Health Issues | $180,000 | LDA ↗ |
| 2026 Q1 | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Health Issues | $90,000 | LDA ↗ |
| 2026 Q1 | CORNERSTONE GOVERNMENT AFFAIRS, INC. | Health Issues | $80,000 | LDA ↗ |
| 2026 Q1 | CAPITOL TAX PARTNERS, LLP | Taxation/Internal Revenue Code | $80,000 | LDA ↗ |
| 2026 Q1 | ACG ADVOCACY | Trade (domestic/foreign) | $60,000 | LDA ↗ |
| 2026 Q1 | TARPLIN, DOWNS & YOUNG, LLC | Health Issues | $60,000 | LDA ↗ |
| 2026 Q1 | MARSHALL & POPP, LLC | Pharmacy | $60,000 | LDA ↗ |
| 2026 Q1 | W STRATEGIES, LLC | Health Issues | $50,000 | LDA ↗ |
| 2026 Q1 | FEDERAL STREET STRATEGIES, LLC | Health Issues | $50,000 | LDA ↗ |
| 2026 Q1 | WILLIAMS AND JENSEN, PLLC | Health Issues | $30,000 | LDA ↗ |
| 2026 Q1 | BAKER & HOSTETLER LLP | — | — | LDA ↗ |
| 2026 Q1 | WILLIAMS AND JENSEN, PLLC | Pharmacy | — | LDA ↗ |
| 2026 Q1 | CHECKMATE GOVERNMENT RELATIONS | Health Issues | — | LDA ↗ |
| 2025 Q4 | ABBVIE, INC. | Copyright/Patent/Trademark | $1,330,000 | LDA ↗ |
| 2025 Q4 | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Health Issues | $80,000 | LDA ↗ |
| 2025 Q4 | CAPITOL TAX PARTNERS, LLP | Taxation/Internal Revenue Code | $80,000 | LDA ↗ |
| 2025 Q4 | TARPLIN, DOWNS & YOUNG, LLC | Health Issues | $60,000 | LDA ↗ |
| 2025 Q4 | CORNERSTONE GOVERNMENT AFFAIRS, INC. | Health Issues | $60,000 | LDA ↗ |
| 2025 Q4 | MARSHALL & POPP, LLC | Pharmacy | $60,000 | LDA ↗ |
| 2025 Q4 | BAKER & HOSTETLER LLP | Taxation/Internal Revenue Code | $60,000 | LDA ↗ |
| 2025 Q4 | ACG ADVOCACY | Trade (domestic/foreign) | $60,000 | LDA ↗ |
| 2025 Q4 | W STRATEGIES, LLC | Health Issues | $50,000 | LDA ↗ |
| 2025 Q4 | FEDERAL STREET STRATEGIES, LLC | Health Issues | $50,000 | LDA ↗ |
| 2025 Q3 | ABBVIE, INC. | Trade (domestic/foreign) | $980,000 | LDA ↗ |
| 2025 Q3 | CAPITOL TAX PARTNERS, LLP | Taxation/Internal Revenue Code | $80,000 | LDA ↗ |
| 2025 Q3 | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Health Issues | $80,000 | LDA ↗ |
| 2025 Q3 | ACG ADVOCACY | Trade (domestic/foreign) | $80,000 | LDA ↗ |
| 2025 Q3 | MARSHALL & POPP, LLC | Pharmacy | $60,000 | LDA ↗ |
| 2025 Q3 | BAKER & HOSTETLER LLP | Taxation/Internal Revenue Code | $60,000 | LDA ↗ |
| 2025 Q3 | TARPLIN, DOWNS & YOUNG, LLC | Health Issues | $60,000 | LDA ↗ |
| 2025 Q3 | CORNERSTONE GOVERNMENT AFFAIRS, INC. | Health Issues | $60,000 | LDA ↗ |
| 2025 Q3 | W STRATEGIES, LLC | Health Issues | $50,000 | LDA ↗ |
| 2025 Q3 | FEDERAL STREET STRATEGIES, LLC | Health Issues | $50,000 | LDA ↗ |
Related companies
Companies whose stock was traded by the same people who traded ABBV, by number of filers in common. It shows overlap in public filings and nothing else.
- MICROSOFT CORP MSFT 5 filers in common
- INTERNATIONAL BUSINESS MACHINES CORP IBM 5 filers in common
- UNITEDHEALTH GROUP INC UNH 5 filers in common
- ABBOTT LABORATORIES ABT 5 filers in common
- GOLDMAN SACHS GROUP INC GS 5 filers in common
- INTUIT INC. INTU 4 filers in common
- ADVANCED MICRO DEVICES INC AMD 4 filers in common
- VERIZON COMMUNICATIONS INC VZ 4 filers in common
Guides for this page
- What is SEC Form 4? Who files: officers, directors and owners of more than 10% of a class of the company's shares.
- Insider buying vs insider selling Selling outweighs buying by a wide margin in normal times.
- Lobbying disclosure reports Reports are due about 20 days after each quarter ends.
- What disclosure data cannot tell you Filings are late by design: up to 45 days for Congress, two business days for insiders.
Sources and method
| Source | Filings | Rows | First filed | Newest filed | Read the originals |
|---|---|---|---|---|---|
| House Clerk, periodic transaction reports | 6 | 11 | November 21, 2025 | September 18, 2026 | House Clerk search |
| Senate eFD, periodic transaction reports | 1 | 1 | July 21, 2026 | July 21, 2026 | Senate eFD search |
| SEC EDGAR, Form 4 | 45 | 90 | October 2, 2025 | October 2, 2026 | Form 4 list on EDGAR |
| Lobbying disclosure filings | 49 filings | — | — | — | LDA.gov search |
Site built October 27, 2026. Every row in the tables above links to its own filing. To quote a figure, use the Cite button at the top of the page; see how to cite and reuse.
Insiders and their transactions come from SEC EDGAR Form 4 filings for this issuer. Contracts and lobbying are matched by exact normalized name (suffixes like Inc./Corp. ignored) to USAspending recipients and LDA clients — a conservative match that misses subsidiaries on purpose. See methodology and corrections.
Not investment advice. Public records shown as filed; no recommendation is made or implied.